AR111313A1 - Composición osmóticamente activa para diálisis - Google Patents
Composición osmóticamente activa para diálisisInfo
- Publication number
- AR111313A1 AR111313A1 ARP180100773A ARP180100773A AR111313A1 AR 111313 A1 AR111313 A1 AR 111313A1 AR P180100773 A ARP180100773 A AR P180100773A AR P180100773 A ARP180100773 A AR P180100773A AR 111313 A1 AR111313 A1 AR 111313A1
- Authority
- AR
- Argentina
- Prior art keywords
- solution
- weight
- content
- total weight
- liquid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
- A61M1/287—Dialysates therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Diabetes (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Toxicology (AREA)
- Obesity (AREA)
- Nutrition Science (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- External Artificial Organs (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Una composición, que comprende: a) un compuesto que se selecciona del grupo que consiste en maltosa, glicerol, un aminoácido, un oligopéptido o una mezcla de uno o más de estos, en un contenido del 5 al 75% en peso del peso total de a) - d), b) glucosa en un contenido menor de 1/2 del contenido de maltosa y en un contenido total menor del 5% en peso del peso total de a) - d), c) moléculas de glucano de DP 3 y DP 4, tomadas en conjunto, en un contenido menor de 1/2 del contenido de maltosa, d) moléculas de glucano de DP>4 en un contenido para dar el 100% en peso junto con a), b) y c), en la que moléculas de glucano de DP>10 están presentes en una cantidad del 15 - 80% en peso del peso total de a) - d), moléculas de glucano de DP>24 están presentes en una cantidad del 2 - 60% en peso del peso total de a) - d), moléculas de glucano de DP>55 están presentes en una cantidad de menos del 15% en peso del peso total de a) - d). Un método para producirlo y sus uso como un medicamento o para usar en terapia, particularmente en diálisis peritoneal. Reivindicación 15: Una composición acuosa líquida, que comprende la composición de una o más de las reivindicaciones 1 - 14 y agua. Reivindicación 16: La composición acuosa líquida de la reivindicación 14, que tiene una osmolalidad de 280 a 450 mosm/kg. Reivindicación 18: La composición de una o más de las reivindicaciones 1 - 14, o la composición acuosa líquida de una o más de las reivindicaciones 15 - 16, para usar como líquido o solución terapéuticos peritoneales, líquido o solución de diálisis, particularmente líquido o solución de diálisis peritoneal, solución gastroenterológica, tal como soluciones de limpieza del tracto digestivo, solución nutricional, infusión nutricional, solución de administración de fármaco, solución desintoxicante, preparación de sustituto o aditivo fisiológica, en particular para fluidos corporales fisiológicos, más particularmente como sustituto o adición de sangre, plasma, suero o fluidos corporales intersticiales, solución reductora de adhesión después de la cirugía, solución para enema, laxante, agente osmótico, particularmente conductor osmótico, dietética infantil, agente con citotoxicidad reducida, o en el tratamiento de enfermedades renales.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17164425.5A EP3381484A1 (en) | 2017-03-31 | 2017-03-31 | Carbohydrate composition for dialysis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR111313A1 true AR111313A1 (es) | 2019-06-26 |
Family
ID=58489186
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP180100773A AR111313A1 (es) | 2017-03-31 | 2018-03-28 | Composición osmóticamente activa para diálisis |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20200397814A1 (es) |
| EP (2) | EP3381484A1 (es) |
| JP (3) | JP2020515323A (es) |
| KR (1) | KR102180431B1 (es) |
| CN (1) | CN110520171B (es) |
| AR (1) | AR111313A1 (es) |
| AU (1) | AU2018218354C1 (es) |
| BR (1) | BR112019020586A2 (es) |
| CA (1) | CA3055677C (es) |
| CO (1) | CO2019010663A2 (es) |
| CY (1) | CY1124029T1 (es) |
| DK (1) | DK3600486T3 (es) |
| ES (1) | ES2864403T3 (es) |
| HR (1) | HRP20210718T1 (es) |
| HU (1) | HUE053951T2 (es) |
| LT (1) | LT3600486T (es) |
| MX (1) | MX2019011646A (es) |
| PL (1) | PL3600486T3 (es) |
| PT (1) | PT3600486T (es) |
| RS (1) | RS61757B1 (es) |
| RU (1) | RU2749443C2 (es) |
| SI (1) | SI3600486T1 (es) |
| TW (1) | TWI763817B (es) |
| WO (1) | WO2018146345A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3381484A1 (en) | 2017-03-31 | 2018-10-03 | Opterion Health AG | Carbohydrate composition for dialysis |
| CN110483649A (zh) * | 2019-08-28 | 2019-11-22 | 西安乐析医疗科技有限公司 | 一种新型糊精的制备方法及其在透析液中的应用 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4182756A (en) | 1977-11-21 | 1980-01-08 | Abbott Laboratories | High calorie solutions of low molecular weight glucose polymer mixtures useful for intravenous administration |
| FR2445839A1 (fr) | 1979-01-08 | 1980-08-01 | Roquette Freres | Hydrolysat d'amidon eventuellement hydrogene, son procede de preparation et ses applications |
| JPS58501077A (ja) | 1981-07-10 | 1983-07-07 | バクスター・インターナショナル・インコーポレイテッド | 炭水化物ポリマ−を含有する腹膜透析液 |
| EP0076355A3 (en) | 1981-10-01 | 1983-05-25 | Abbott Laboratories | Improved peritoneal dialysis solution |
| US4886789A (en) | 1983-01-12 | 1989-12-12 | M. L. Laboratories Plc | Peritoneal dialysis and compositions for use therein |
| US6077836A (en) * | 1983-01-12 | 2000-06-20 | Ml Laboratotries, Plc | Peritoneal dialysis and compositions for use therein |
| GB8404299D0 (en) * | 1984-02-18 | 1984-03-21 | Milner Research Ireland Ltd | Peritoneal dialysis |
| GB8300718D0 (en) | 1983-01-12 | 1983-02-16 | Milner Research Ireland Ltd | Glucose polymer solutions |
| US6248726B1 (en) | 1985-06-22 | 2001-06-19 | M L Laboratories Plc | Method of peritoneal dialysis using glucose polymer solutions |
| ATE106410T1 (de) * | 1985-06-22 | 1994-06-15 | Ml Lab Plc | In kontinuierlicher peritonealdialyse verwendete polymere. |
| DE4123001A1 (de) * | 1991-07-11 | 1993-01-14 | Laevosan Gmbh & Co Kg | Pharmazeutische zusammensetzung fuer die peritonealdialyse |
| US6306836B1 (en) * | 1994-01-21 | 2001-10-23 | Baxter International Inc. | Peritoneal dialysis solutions containing maltodextrins and amino acids |
| FR2840612B1 (fr) * | 2002-06-06 | 2005-05-06 | Roquette Freres | Polymeres solubles de glucose hautement branches et leur procede d'obtention |
| FR2864088B1 (fr) * | 2003-12-19 | 2006-04-28 | Roquette Freres | Polymeres solubles de glucose hautement branches |
| US8193341B2 (en) | 2006-04-28 | 2012-06-05 | Bayer Cropscience Ag | Inulin of very high chain length |
| FR2955861B1 (fr) * | 2010-02-02 | 2013-03-22 | Roquette Freres | Polymeres solubles de glucose branches pour la dialyse peritoneale |
| US8724336B2 (en) | 2010-07-02 | 2014-05-13 | National Instruments Corporation | Card guide system and method |
| EP2685991A1 (en) * | 2011-03-18 | 2014-01-22 | Baxter International Inc | Peritoneal dialysis solutions comprising glucose polymers |
| MY170307A (en) * | 2012-04-24 | 2019-07-17 | Univ British Columbia | Polymer-based dialysate |
| EP3120842A1 (en) * | 2015-07-20 | 2017-01-25 | Opterion Health AG | Peritoneal therapeutic fluid |
| EP3381484A1 (en) | 2017-03-31 | 2018-10-03 | Opterion Health AG | Carbohydrate composition for dialysis |
-
2017
- 2017-03-31 EP EP17164425.5A patent/EP3381484A1/en not_active Withdrawn
-
2018
- 2018-03-22 ES ES18714471T patent/ES2864403T3/es active Active
- 2018-03-22 BR BR112019020586A patent/BR112019020586A2/pt unknown
- 2018-03-22 AU AU2018218354A patent/AU2018218354C1/en active Active
- 2018-03-22 US US15/780,214 patent/US20200397814A1/en active Pending
- 2018-03-22 LT LTEP18714471.2T patent/LT3600486T/lt unknown
- 2018-03-22 CN CN201880023467.4A patent/CN110520171B/zh active Active
- 2018-03-22 EP EP18714471.2A patent/EP3600486B1/en active Active
- 2018-03-22 JP JP2019552910A patent/JP2020515323A/ja active Pending
- 2018-03-22 RU RU2019134107A patent/RU2749443C2/ru active
- 2018-03-22 SI SI201830232T patent/SI3600486T1/sl unknown
- 2018-03-22 HU HUE18714471A patent/HUE053951T2/hu unknown
- 2018-03-22 PT PT187144712T patent/PT3600486T/pt unknown
- 2018-03-22 CA CA3055677A patent/CA3055677C/en active Active
- 2018-03-22 PL PL18714471T patent/PL3600486T3/pl unknown
- 2018-03-22 DK DK18714471.2T patent/DK3600486T3/da active
- 2018-03-22 MX MX2019011646A patent/MX2019011646A/es unknown
- 2018-03-22 RS RS20210496A patent/RS61757B1/sr unknown
- 2018-03-22 WO PCT/EP2018/057275 patent/WO2018146345A1/en unknown
- 2018-03-22 KR KR1020197028685A patent/KR102180431B1/ko active IP Right Grant
- 2018-03-28 AR ARP180100773A patent/AR111313A1/es unknown
- 2018-03-30 TW TW107111274A patent/TWI763817B/zh active
-
2019
- 2019-09-27 CO CONC2019/0010663A patent/CO2019010663A2/es unknown
-
2021
- 2021-04-05 JP JP2021064226A patent/JP7126091B2/ja active Active
- 2021-04-14 CY CY20211100327T patent/CY1124029T1/el unknown
- 2021-05-07 HR HRP20210718TT patent/HRP20210718T1/hr unknown
-
2022
- 2022-07-22 JP JP2022117201A patent/JP7411268B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2395369T5 (es) | Soluciones basadas en bicarbonato para terapias de diálisis | |
| JP2021503468A5 (es) | ||
| JP2013543492A5 (es) | ||
| ES2971959T3 (es) | Terlipresina para el tratamiento de la ascitis debida a cirrosis hepática administrada como una infusión continua | |
| JP6648106B2 (ja) | 自己消化の治療用組成物 | |
| CO6592015A2 (es) | Métodos y composiciones para reducir o prevenir la cladificación vascular durante el tratamiento de diálisis peritoneal | |
| AR111313A1 (es) | Composición osmóticamente activa para diálisis | |
| AR123570A1 (es) | Tratamientos para el edema macular diabético y la agudeza visual disminuida | |
| MX2019008482A (es) | Tratamiento medico que comprende administracion enteral de edaravona. | |
| WO2019043613A1 (en) | SODIUM-GLUCOSE COTRANSPORTING INHIBITORS (SGLT) FOR ENHANCED PERITONEAL DIALYSIS | |
| CN103263383A (zh) | 双室袋丙酮酸钠水溶液试剂盒及其用途 | |
| JP5291319B2 (ja) | ヘパリン製剤 | |
| RU2015145451A (ru) | Препараты для местного применения, содержащие гиалуроновую кислоту, вербаскозид и глицерофосфоинозитол | |
| WO2017181978A1 (zh) | 贻贝粘蛋白产品及其抑制血管炎症的应用 | |
| JP2009142436A (ja) | 透析用水溶液 | |
| WO2016180363A1 (en) | Chitosan citrate and composition containing same | |
| TW201420130A (zh) | 溶解有二氧化碳之液狀藥劑及其投藥方法 | |
| Pantaleon | Fluid therapy in equine patients: small-volume fluid resuscitation | |
| WO2000010576A1 (en) | Method of producing means for treating the human body | |
| CN101579307A (zh) | 高渗注射剂在制备促进伤口愈合药物中的用途 | |
| CN104887697A (zh) | 氨基多糖季铵盐组合物及其应用、制剂 | |
| Terlizzi et al. | Therapeutic Challenge | |
| Oh et al. | Surgical Treatment of Recurrent Vocal Process Granuloma using Carbon-dioxide Laser and Mitomycin-C | |
| JP2016190833A (ja) | 水素分子による乾癬患者における皮膚関節症状およびサイトカイン改善作用 | |
| JP2014528477A5 (ja) | 急性腎臓損傷を治療するための組成物及び溶液 |